A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

Stephen Beard; M Lothgren; L Giudi; F Ramacciotti; M Nardini; D Berardi

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

Beard, S., Lothgren, M., Giudi, L., Ramacciotti, F., Nardini, M., & Berardi, D. (2002). A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy. Value in Health, 5(6), 515-515.

Copy citation

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

A cost-effectiveness comparison of olanzapine and risperidone in the treatment of schizophrenia in Italy

Publications Info

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Article

"Show Me the Energy Costs"

Chapter

Finding a way to survive

Article

A new approach to a legacy concern